Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value:
$819.65M
Total Bought:
$0
Total Sold:
$150.09M
Net Transaction:
-$150.09M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)4,896,4624,896,4620$231.75M$196.98M24.03%-$34.76M
Dyne Therapeutics, Inc.(DYN)8,020,1368,019,354-782$288.08M$188.94M23.05%-$99.15M
Disc Medicine, Inc.(IRON)2,509,4562,509,4560$123.31M$159.10M19.41%+$35.78M
Third Harmonic Bio, Inc.10,907,85910,402,286-505,573$147.80M$107.04M13.06%-$40.76M
Day One Biopharmaceuticals, Inc.
COM
6,430,2576,430,2570$89.57M$81.47M9.94%-$8.10M
Korro Bio, Inc.(KRRO)1,137,1491,137,1490$38.00M$43.29M5.28%+$5.29M
Vigil Neuroscience, Inc.5,836,8745,836,8740$19.85M$9.92M1.21%-$9.92M
Generation Bio, Co.8,279,4848,279,4840$20.45M$8.78M1.07%-$11.67M
Ikena Oncology, Inc.5,018,1785,018,1780$8.68M$8.23M1.00%-$451.6K
Q32 Bio Inc.(QTTB)2,092,1062,092,1060$93.35M$7.20M0.88%-$86.15M
Aerovate Therapeutics, Inc.1,799,2321,799,2320$3.76M$4.77M0.58%+$1.01M
Tectonic Therapeutic, Inc.(TECX)378,44778,447-300,000$11.47M$3.62M0.44%-$7.85M
Spero Therapeutics, Inc.(SPRO)402,885305,255-97,630$539.9K$314.4K0.04%-$225.5K
Dianthus Therapeutics, Inc.(DNTH)76,9790-76,979$2.11M$0—-$2.11M
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q4 2024 | TickerTrail